Teva Pharmaceutical Industries (TEVA) FCF Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn | 213.00 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -291.00 |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -1,879.00 |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.33 Bn | 334.51 Mn | -263.00 |
| 5 | Bausch Health Companies | 2.37 Bn | 528.25 Mn | 2.10 Bn | 1,258.00 |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 46,147.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 460.00 |
| 8 | Amphastar Pharmaceuticals | 992.90 Mn | 702.78 Mn | 93.47 Mn | -824.00 |
| 9 | Fennec Pharmaceuticals | 411.43 Mn | 370.18 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 181.39 Mn | 181.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 213.00 |
| Mar 31, 2026 | 253.00 |
| Dec 31, 2025 | 17.00 |
| Sep 30, 2025 | -651.00 |
| Jun 30, 2025 | 324.00 |
| Mar 31, 2025 | -34.00 |
| Dec 31, 2024 | 799.00 |
| Sep 30, 2024 | 273.00 |
| Jun 30, 2024 | -254.00 |
| Mar 31, 2024 | 744.00 |
| Dec 31, 2023 | 2,041.00 |
| Sep 30, 2023 | -786.00 |
| Jun 30, 2023 | 162.00 |
| Mar 31, 2023 | -1,182.00 |
| Dec 31, 2022 | 1,202.00 |
| Sep 30, 2022 | 790.00 |
| Jun 30, 2022 | 801.00 |
| Mar 31, 2022 | -531.00 |
| Dec 31, 2021 | 391.00 |
| Sep 30, 2021 | 342.00 |